The Trans-Pacific Partnership (TPP): A Threat to Affordable Medicines for Millions
The TPP trade deal is currently being negotiated between the US and ten other Pacific Rim nations: Australia, Brunei Darussalam, Canada, Chile, Malaysia, Mexico, New Zealand, Peru, Singapore and Vietnam. The agreement is slated to further expand its membership, potentially to all 21 Asia Pacific APEC nations. The negotiations, which began in 2010, are being conducted in secret, without the opportunity for public scrutiny. However, leaked drafts of the United States government’s proposals for some sections of the agreement reveal the inclusion of dangerous provisions that would dismantle public health safeguards enshrined in international law and restrict access to affordable generic medicines for millions of people in developing countries. To learn more visit, msfaccess.org/TPP
MSF Access: Dear GAVI Campaign
The GAVI Alliance negotiates price reductions for newer vaccines and, through its donors (such as the UK, the US and Norway), pays for these vaccines to be introduced in developing countries. MSF fully supports GAVI’s mission, but is concerned that the prices agreed for vaccines are still too high, and wants GAVI to put more pressure on the pharmaceutical companies to bring prices down further.
Help MSF, send GAVI a message on Twitter asking for them to open up their lower prices to non-governmental organisations and humanitarian actors like MSF now.
BREAKING NEWS
Novartis has lost its case in Indian Supreme Court today, protecting access to affordable, quality medicines for people in developing countries.
Test Me, Treat Me: A Drug-Resistant TB Manifesto
The cost of DR-TB drugs are so high that most of the people affected by DR-TB do not have access to life saving medications. For the “lucky” ones that do have access, the treatment is long and painful. It can take up to 2 years, 14,6000 pills, and 8 months worth of daily injections to cure DR-TB. Many people living with DR-TB drop out of treatment plans because it severely hampers daily functioning and ability to maintain a normal lifestyle.
We need better treatment now! Learn more about the manifesto.
CHANGE IS NEEDED: People living with drug-resistant TB & doctors are calling on the international community to seize an historic opportunity to develop newer, shorter, better treatments.
A ‘Potential Game-Changer’ for drug-resistant TB treatment
The first new TB drug since 1963 has received U.S. Food and Drug Administration approval.
Several pharmaceutical companies have abandoned HIV drug discount programs in middle-income countries, according to an HIV drug price report released today by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) at the International AIDS Society Conference in Rome. Full press release.
In Rio’s Complexo do Alemão, a group of favelas rife with violence from drug traffickers and police, but with no access to emergency medical services, MSF ran a project from 2007 to 2009. Staff gave 19,000 medical consultations and made 650 emergency rescues.
(Photo: Brazil 2009 © David Prichard)
Read more.